Views
3 years ago

Program Book - Confex

Program Book - Confex

Program Book -

program B O O K Pre-Conference Courses: Friday, November 4 – Saturday, November 5, 2011 Annual Scientific Sessions: Saturday, November 5 – Wednesday, November 9, 2011 Exhibits: Sunday, November 6 – Tuesday, November 8, 2011 to the premier meeting in rheumatology

  • Page 2 and 3: IMPORTANT LOCATIONS ACR Office ....
  • Page 4 and 5: ACR/ARHP 2011 ANNUAL SCIENTIFIC MEE
  • Page 6 and 7: TABLE OF CONTENTS ACR State-of-the-
  • Page 8 and 9: TABLE OF CONTENTS Systemic Lupus Er
  • Page 10 and 11: The most comprehensive online colle
  • Page 12 and 13: ACR Medical Aspects of Rheumatic Di
  • Page 14 and 15: ACR Resource Center Located in the
  • Page 16 and 17: 14 2011 Program Book 2011 REF 5K RU
  • Page 19 and 20: FRIDAY, NOVEMBER 4, 2011 ACR/ARHP R
  • Page 21 and 22: 2:15 pm Innate Immunity: Role of Im
  • Page 23 and 24: 9:15 am Bone Remodeling in Osteoart
  • Page 25 and 26: • construct a therapeutic plan fo
  • Page 27 and 28: ACR/ARHP OPENING EVENT 7:00 - 10:00
  • Page 29 and 30: • identify how glucocorticoids al
  • Page 31 and 32: Rheumatoid Arthritis Treatment - Sm
  • Page 33 and 34: 11:45 am 720. The Value of Periodic
  • Page 35 and 36: W186b Vitamin D and Bone Health (02
  • Page 37 and 38: 2:30 pm 723. Involvement of TLR7 an
  • Page 39 and 40: California-San Francisco, San Franc
  • Page 41 and 42: V. Michael Holers7 and Jill M. Norr
  • Page 43 and 44: A. Silva 9 , Gloria Vázquez 10 , M
  • Page 45 and 46: ARHP CONCURRENT ABSTRACT SESSION 2:
  • Page 47 and 48: 5:20 pm Management of Pregnancy Lis
  • Page 49 and 50: 4:30 pm 819. Micrornas Mir-15b and
  • Page 51 and 52: Berlin, Germany, 2 Charité - Unive
  • Page 53 and 54:

    5:45 pm 860. Causes and Prognostic

  • Page 55 and 56:

    5:00 pm 869. Clinical Decision Supp

  • Page 57 and 58:

    Speakers: Charles G. Helmick, MD; C

  • Page 59 and 60:

    ACR/ARHP POSTER SESSION B AND POSTE

  • Page 61 and 62:

    W179b Osteoporosis: Interpreting Du

  • Page 63 and 64:

    noon An Electronic Health Record Is

  • Page 65 and 66:

    ACR SPECIAL SESSION 1:00 - 2:00 pm

  • Page 67 and 68:

    3:00 pm 1595. Knowledge of Clinical

  • Page 69 and 70:

    Moderators: Peter Simkin, MD; Unive

  • Page 71 and 72:

    3:30 pm 1639. Inflammatory Arthriti

  • Page 73 and 74:

    Michelle Petri 1 , Hong Fang 1 and

  • Page 75 and 76:

    2:30 pm Biomechanical Mechanisms Co

  • Page 77 and 78:

    MN, 2 Massachusetts General Hospita

  • Page 79 and 80:

    5:15 pm 1692. Low Persistence of Se

  • Page 81 and 82:

    Birmingham, AL, 3 University of Bir

  • Page 83 and 84:

    5:00 pm ILAR COPCORD Repository Arv

  • Page 85 and 86:

    Toronto, ON, 2 Health Care and Outc

  • Page 87 and 88:

    REF 5K RUN/WALK 6:00 - 8:00 am TUES

  • Page 89 and 90:

    W186b Osteoarthritis: Update 2011 (

  • Page 91 and 92:

    9:00 - 9:45 am Miscellaneous Rheuma

  • Page 93 and 94:

    ACR CLINICAL SYMPOSIUM 11:00 am - n

  • Page 95 and 96:

    W474b Fiscal Management of Infusion

  • Page 97 and 98:

    W178b Histopathology of Vasculitis

  • Page 99 and 100:

    W194b Epidemiology and Health Servi

  • Page 101 and 102:

    W196b Rheumatoid Arthritis Clinical

  • Page 103 and 104:

    3:30 pm 2473. Allogeneic Mesenchyma

  • Page 105 and 106:

    Consultants LLC, Avon, CT, 2 Johns

  • Page 107 and 108:

    3:00 pm 2489. Sexual Activity and I

  • Page 109 and 110:

    5:20 pm Fibrocytes in Autoimmune Fi

  • Page 111 and 112:

    4:45 pm 2500. Interleukin-27 Recept

  • Page 113 and 114:

    5:45 pm 2522. Heightened Immune Res

  • Page 115 and 116:

    5:45 pm 2540. The Nuclear Receptor

  • Page 117 and 118:

    ARHP CONCURRENT SESSIONS 4:30 - 6:0

  • Page 119 and 120:

    de Rehabilitación Psicofísica, Bu

  • Page 121 and 122:

    ACR CURRENT ABSTRACT SESSIONS 9:00

  • Page 123 and 124:

    10:15 am 2590. Getting to the Heart

  • Page 125 and 126:

    Peter J. Wermuth 1 , Sankar Addya 2

  • Page 127 and 128:

    9:00 am Introduction to Comparative

  • Page 129 and 130:

    Quartier 2 , Tamás Constantin 2 ,

  • Page 131 and 132:

    Mondor, Service de Santé Publique,

  • Page 133 and 134:

    ACR Poster Session A SUNDAY, NOVEMB

  • Page 135 and 136:

    ACR Poster Session A 24. Prevalence

  • Page 137 and 138:

    ACR Poster Session A Higashi-hirosh

  • Page 139 and 140:

    ACR Poster Session A 79. Polymyalgi

  • Page 141 and 142:

    ACR Poster Session A Southborough,

  • Page 143 and 144:

    ACR Poster Session A et Marie Curie

  • Page 145 and 146:

    ACR Poster Session A Santra 4 , Har

  • Page 147 and 148:

    ACR Poster Session A 174. Metrologi

  • Page 149 and 150:

    ACR Poster Session A Malte Bahner 5

  • Page 151 and 152:

    ACR Poster Session A Kingdom, 7 Wal

  • Page 153 and 154:

    ACR Poster Session A 249. Increased

  • Page 155 and 156:

    ACR Poster Session A 271. Race and

  • Page 157 and 158:

    ACR Poster Session A Pediatric Rheu

  • Page 159 and 160:

    ACR Poster Session A 316. The New E

  • Page 161 and 162:

    ACR Poster Session A 340. Performan

  • Page 163 and 164:

    ACR Poster Session A 363. A New Def

  • Page 165 and 166:

    ACR Poster Session A Baeuerle 2 , M

  • Page 167 and 168:

    ACR Poster Session A 407. Tofacitin

  • Page 169 and 170:

    ACR Poster Session A 425. Glucoster

  • Page 171 and 172:

    ACR Poster Session A and Kristel Lu

  • Page 173 and 174:

    ACR Poster Session A United Kingdom

  • Page 175 and 176:

    ACR Poster Session A 487. Cathepsin

  • Page 177 and 178:

    ACR Poster Session A 3 Hospital Gar

  • Page 179 and 180:

    ACR Poster Session A 532. Prevalenc

  • Page 181 and 182:

    ACR Poster Session A 558. TNFα Inh

  • Page 183 and 184:

    ACR Poster Session A 587. Cystatin

  • Page 185 and 186:

    ACR Poster Session A 603. Vascular

  • Page 187 and 188:

    ACR Poster Session A 627. Risk Fact

  • Page 189 and 190:

    ACR Poster Session A Research Found

  • Page 191 and 192:

    ACR Poster Session A Gauthier 1 , A

  • Page 193 and 194:

    ACR Poster Session A Netherlands, 3

  • Page 195 and 196:

    ACR Poster Session A Wilson 3 and J

  • Page 197 and 198:

    ACR/ARHP Poster Session B MONDAY, N

  • Page 199 and 200:

    ACR/ARHP Poster Session B Toward He

  • Page 201 and 202:

    ACR/ARHP Poster Session B Center, N

  • Page 203 and 204:

    ACR/ARHP Poster Session B Pittsburg

  • Page 205 and 206:

    ACR/ARHP Poster Session B Meini 2 ,

  • Page 207 and 208:

    ACR/ARHP Poster Session B Pennsylva

  • Page 209 and 210:

    ACR/ARHP Poster Session B 1041. Tre

  • Page 211 and 212:

    ACR/ARHP Poster Session B Osteoarth

  • Page 213 and 214:

    ACR/ARHP Poster Session B Solutions

  • Page 215 and 216:

    ACR/ARHP Poster Session B 1119. Pos

  • Page 217 and 218:

    ACR/ARHP Poster Session B 1149. Imp

  • Page 219 and 220:

    ACR/ARHP Poster Session B 1173. Eff

  • Page 221 and 222:

    ACR/ARHP Poster Session B 1 McGill

  • Page 223 and 224:

    ACR/ARHP Poster Session B 1216. Bas

  • Page 225 and 226:

    ACR/ARHP Poster Session B 1235. Gre

  • Page 227 and 228:

    ACR/ARHP Poster Session B Rheumatic

  • Page 229 and 230:

    ACR/ARHP Poster Session B 1280. Acu

  • Page 231 and 232:

    ACR/ARHP Poster Session B 1309. Ser

  • Page 233 and 234:

    ACR/ARHP Poster Session B 1334. Doe

  • Page 235 and 236:

    ACR/ARHP Poster Session B 1362. The

  • Page 237 and 238:

    ACR/ARHP Poster Session B 11 Northw

  • Page 239 and 240:

    ACR/ARHP Poster Session B Medical C

  • Page 241 and 242:

    ACR/ARHP Poster Session B 1439. Ant

  • Page 243 and 244:

    ACR/ARHP Poster Session B Distler 9

  • Page 245 and 246:

    ACR/ARHP Poster Session B 1490. A M

  • Page 247 and 248:

    ACR/ARHP Poster Session B School of

  • Page 249 and 250:

    ACR/ARHP Poster Session B Apparato

  • Page 251 and 252:

    ACR/ARHP Poster Session B ARHP Reha

  • Page 253 and 254:

    ACR/ARHP Poster Session C TUESDAY,

  • Page 255 and 256:

    ACR/ARHP Poster Session C 1760. B C

  • Page 257 and 258:

    ACR/ARHP Poster Session C Joana Cae

  • Page 259 and 260:

    ACR/ARHP Poster Session C Laguna, S

  • Page 261 and 262:

    ACR/ARHP Poster Session C Program.

  • Page 263 and 264:

    ACR/ARHP Poster Session C Siobhan O

  • Page 265 and 266:

    ACR/ARHP Poster Session C 1908. Imp

  • Page 267 and 268:

    ACR/ARHP Poster Session C Martini,

  • Page 269 and 270:

    ACR/ARHP Poster Session C 1960. Idi

  • Page 271 and 272:

    ACR/ARHP Poster Session C 1988. Psy

  • Page 273 and 274:

    ACR/ARHP Poster Session C Kathleen

  • Page 275 and 276:

    ACR/ARHP Poster Session C Loic de P

  • Page 277 and 278:

    ACR/ARHP Poster Session C 2060. Ass

  • Page 279 and 280:

    ACR/ARHP Poster Session C Lee, Yong

  • Page 281 and 282:

    ACR/ARHP Poster Session C 2117. Ear

  • Page 283 and 284:

    ACR/ARHP Poster Session C 2141. Fun

  • Page 285 and 286:

    ACR/ARHP Poster Session C 2161. The

  • Page 287 and 288:

    ACR/ARHP Poster Session C Rheumatoi

  • Page 289 and 290:

    ACR/ARHP Poster Session C 2207. Opt

  • Page 291 and 292:

    ACR/ARHP Poster Session C 2228. Ini

  • Page 293 and 294:

    ACR/ARHP Poster Session C PingAr Ya

  • Page 295 and 296:

    ACR/ARHP Poster Session C 2273. Cli

  • Page 297 and 298:

    ACR/ARHP Poster Session C Istanbul,

  • Page 299 and 300:

    ACR/ARHP Poster Session C 2330. Hum

  • Page 301 and 302:

    ACR/ARHP Poster Session C 2362. Ide

  • Page 303 and 304:

    ACR/ARHP Poster Session C 2388. Gen

  • Page 305 and 306:

    ACR/ARHP Poster Session C 2412. The

  • Page 307 and 308:

    REF Industry Roundtable-supported S

  • Page 309 and 310:

    Industry-supported POST-CONFERENCE

  • Page 311 and 312:

    ACR REF Industry Roundtable The Ind

  • Page 313 and 314:

    2011 ACR/ARHP Annual Meeting Leader

  • Page 315 and 316:

    2011 ACR/ARHP Annual Meeting Leader

  • Page 317 and 318:

    Explore the Exhibit Hall! Sunday, N

  • Page 319 and 320:

    EXHIBITORS Esaote North America Dia

  • Page 321 and 322:

    EXHIBITORS Savient Pharmaceuticals

  • Page 323 and 324:

    acknowledgements In addition to the

  • Page 325 and 326:

    Belza, Basia, PhD New and Noteworth

  • Page 327 and 328:

    Cush, John J., MD Rheumatology Roun

  • Page 329 and 330:

    Giltiay, Natalia V. ACR REF Edmond

  • Page 331 and 332:

    Kaiser, Rachel, MD, MPH Mechanisms

  • Page 333 and 334:

    Manzi, Susan, MD Biomarkers in Syst

  • Page 335 and 336:

    Pincus, Theodore, MD Patient Questi

  • Page 337 and 338:

    Shah, Ami A., MD, MHS ACR Plenary S

  • Page 339 and 340:

    van der Heijde, Desiree, MD, PhD An

  • Page 341 and 342:

    A Aalbers, CJ 1147 Aarden, L 464, 1

  • Page 343 and 344:

    Attinger, C 27, 1953 Bader-Meunier,

  • Page 345 and 346:

    Bjornsson, J 2439, 2546 Blachier, M

  • Page 347 and 348:

    Cao, Y 2202 Cao, Y 1760 Caorsi, R 1

  • Page 349 and 350:

    Collier, DH 326 Collins, CE 85, 159

  • Page 351 and 352:

    DeVellis, RF 2418 Devenport, J 434,

  • Page 353 and 354:

    Federici, L 1500 Federici, S 2452 F

  • Page 355 and 356:

    Gay, RE 42, 45, 46, 366, 989, 1671,

  • Page 357 and 358:

    Hahn, BH 568, 572, 574, 593, 639, 6

  • Page 359 and 360:

    Houssiau, F 2472 Houssiau, F 2469 H

  • Page 361 and 362:

    Juengel, A 1923 Julian, LJ 1436, 20

  • Page 363 and 364:

    Klareskog, L 104, 767, 842, 1677, 1

  • Page 365 and 366:

    Lee, H 1765, 1925 Lee, H 1681, 2168

  • Page 367 and 368:

    Lyman, SL 1709, 2151 Lynch, D 769,

  • Page 369 and 370:

    McMurtry, MS 2078 McNeil, HP 1149,

  • Page 371 and 372:

    Myositis Genetics Consortium 1678 M

  • Page 373 and 374:

    Ostergaard, M 955, 1334 Østergaard

  • Page 375 and 376:

    Plou, MS 1401 Poddubnyy, D 515, 777

  • Page 377 and 378:

    Ringe, J 1104 Ringold, S 278, 721 R

  • Page 379 and 380:

    Schanberg, LE 256, 280, 721, 747, 1

  • Page 381 and 382:

    Soejima, M 393, 823, 844, 979 Soeve

  • Page 383 and 384:

    Tanaka, M 44 Tanaka, M 117 Tanaka,

  • Page 385 and 386:

    van Caam, APM 1783 Van der Wee, N 1

  • Page 387 and 388:

    Weinstein, SP 1013, 1014, 1015, 102

  • Page 389 and 390:

    Zaenker, M 1155 Zafar, S 1581 Zahr,

  • Page 391 and 392:

    ack pain 880, 1067, 1068, 1290, 171

  • Page 393 and 394:

    H hand disorders 95, 962, 963, 1070

  • Page 395 and 396:

    1020, 1028, 1029, 1048, 1069, 1079,

  • Page 397 and 398:

    TGF-beta 849 thrombocytopenia 727 t

  • Page 399 and 400:

    Dore, Robin K., MD Osteoporosis and

  • Page 401 and 402:

    Parks, Christine G., PhD ACR/ARHP C

  • Page 403 and 404:

    2011 Fellows Education Fund Through

  • Page 405 and 406:

    Enbrel ® (etanercept) Brief Summar

  • Page 407 and 408:

    Prescription Enbrel ® (etanercept)

registration & preliminary program - Confex
an observational study - Confex
Program Book - ISCD
Program Book and Abstracts - ISCD